Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (531-540 of 632) with videos related to

Pageof 64
Sort By:
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2020
<sup>68</sup>Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy ResultsChen Liu, Teli Liu, Zhongyi Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
Integrative and Comparative Biology|May 19, 2022
Gut Microbial Ecology of Five Species of Sympatric Desert Rodents in Relation to Herbivorous and Insectivorous Feeding StrategiesKevin D Kohl, Etan Dieppa-Colón, José Goyco-Blas, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approvalRavindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA DynamicsLiam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CTRudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyLiang Dong, Yun Su, Yinjie Zhu, et al.
Cancers|January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CTPatrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances|July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomographyIl Minn, David J Huss, Hye-Hyun Ahn, et al.
Pageof 64

Showing results (531-540 of 632) with videos related to

Sort By:
Pageof 64
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2020
<sup>68</sup>Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy ResultsChen Liu, Teli Liu, Zhongyi Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
Integrative and Comparative Biology|May 19, 2022
Gut Microbial Ecology of Five Species of Sympatric Desert Rodents in Relation to Herbivorous and Insectivorous Feeding StrategiesKevin D Kohl, Etan Dieppa-Colón, José Goyco-Blas, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approvalRavindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA DynamicsLiam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CTRudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyLiang Dong, Yun Su, Yinjie Zhu, et al.
Cancers|January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CTPatrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances|July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomographyIl Minn, David J Huss, Hye-Hyun Ahn, et al.
Pageof 64